$1,099 – $1,900

12th World Congress on Dementia and Alzheimer Rehabilitation (CSE) AS

Event Information

Share this event

Date and Time

Location

Location

Venue will be informed to the Registered Participants

Stockholm

Sweden

View Map

Refund Policy

Refund Policy

No Refunds

Event description

Description

12th World Congress on Dementia and Alzheimer Rehabilitation

About Conference

It’s with great pleasure and great honor to invite you to the “12th World Congress on Dementia and Alzheimer Rehabilitation” scheduled during April 11-12, 2019 Stockholm, Sweden.

Welcome to most exciting and fascinating city Stockholm, Sweden.

Within this splendid setting, we plan to deliver a conference that will exceed your expectations. Our event aims to make people with Dementia feel safe and to create a familiar environment for them.

During this year’s Conference, we hope that you will seize the opportunity to rekindle on-going connections and spark new ones with your colleagues from around the globe.

The Conference will be organized around the theme “Innovative Approaches to Support: Dementia & Alzheimer Rehabilitation”.

Dementia Meetings 2019 anticipates more than 500 participants around the globe to experience thought provoking Keynote lectures, Oral & Poster presentations. This year conference will offer ample opportunities for all stakeholders working on Dementia, Alzheimer’s and neurology to expose their research work.

Our conference aims to gather the researchers, principal investigators, experts, neurologists and researchers working on brain from both academia and health care industry, Business Delegates, Scientists and students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.

This year’s Conference program, coupled with the Business Opportunity Exchange, is an event you can’t afford to miss!

Why to attend?

12th World Congress on Dementia and Rehabilitation is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading Neurologists, health professionals involved in the profession and practice of neuroscience. The event will also reflect interest of specialists in the clinical research on dementia and Alzheimer’s disease. Conference series organizing this international event for people to take part and gain a better understanding of such diseases, to access treatment as well as information, advice and support and to have their health monitored more closely.

This International meeting is an effort to make possible interactions among world leading scientists, research scholars, professionals, young researchers from different parts of the world to exchange their knowledge and conduct symposia, show experiments with new innovative techniques that disseminate information about clinical tradition, best practices, skills and knowledge in the field of neuroscience. In Dementia and Rehabilitation 2019, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.

Sessions/Tracks


Dementia and Rehabilitation describes a set of symptoms include memory loss and difficulties with thinking or reasoning that reduce a person ability to perform everyday activities. Dementia is mainly caused when the brain is damaged by diseases, such as Alzheimer’s disease or a series of strokes. This disease mainly affects people over the age of 65 and the likelihood of developing dementia increases significantly with age. However, dementia can affect younger people too.

The conference scientific Tracks on:

Track 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type.

1:Dementia with Lewy Bodies

2:Mixed dementia.

3:Frontotemporal dementia.

4:Normal pressure hydrocephalus

5:Signs and symptoms of dementia

Track 2: Alzheimer’s Disease

Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is not a normal part of aging.

1:Risk Factors of alzheimers

2:Diagnosis of alzheimers

3:Treatments of alzheimers

4:Clinical Studies of alzheimers

5:Alzheimer’s disease Pathophysiology and Disease Mechanisms

Track 3: Dementia and Ageing

Aging: Not being able to remember details of a conversation or event that took place a year ago, Not being able to remember the name of an acquaintance, Forgetting things and events occasionally, Occasionally have difficulty finding words, You are worried about your memory but your relatives are not..

Dementia: Not being able to recall details of recent events or conversations, Not recognizing or knowing the names of family members, Forgetting things or events more frequently, Frequent pauses and substitutions when finding words, Your relatives are worried about your memory, but you are not aware of any problems

1:Neuro-anatomical changes in ageing

2:Risk factors of cognitive decline

3:Granulovacuolar degeneration

4:Changes in cerebral cortical microvasculature

5:Advances of research in ageing and dementia

Track 4: Vascular Dementia

Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

1:Vascular dementia prognosis

2:Young onset dementia

3:Multi-infarct dementia

4:Mixed dementia

5:Parkinson dementia

6:Advences in vascular dementia therapy

Track 5: Geriatrics Dementia and Cognitive Disorders

Geriatrics or geriatric medication may be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. there's no set age at that patients are also underneath the care of a specialist or geriatric .

1:Delirium

2:Mild and Major Neurocognitive Disorder

Track 6: Animal Models in Dementia

The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

1:Neurobehavioral Toxicology Testing

2:pre-clinical testing and clinical translation

3:Protein-protein interactions

4:Genetics of translational models

5:Animal models of human cognitive aging

Track 7: Amyloid Protein in Alzheimer’s and Dementia

Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.

1:Amyloid Imaging

2:FDG-PET

3:Amyloid Immunotherapy

Track 8: Dementia Care Management

The developing number of vascular dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance dementia patients and guardians care and administrations conveyance.

1:Advances in dementia care management

2:Dementia care management program

3:Undernutrition and obesity in dementia

4:Advance care planning

Track 9: Dementia Nursing

People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities.

1:Dementia nursing care plan

2:Music therapy in dementia

3:Physiotherapy for dementia

4:Clinical features of dementia

5:Therapeutic interventions in dementia

Track 10: Treating Dementia

Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable .Ischemic changes in the cerebrum are irreversible, however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus.

1:Primary mental health care and nursing

2:Psychopharmacological treatment

3:Advanced drugs for dementia

4:Cognitive behavioral therapy

5:Family therapy in nursing

AGENDA - 2017
-----------------------------
2018 Upcoming soon
-----------------------------
-----------------------------
07:30-08:30 Registrations
Day 1 February 27, 2017
-----------------------------
Keynote Forum
09:00-09:40
Title: Nonlinear impacts on human brain for recovering of physiological and mental activity and for
rehabilitation in extreme ambient conditions
Marina Zueva, Moscow Helmholtz Research Institute of Eye Diseases, Russia

09:40-10:20
Title: Spring Break: A True Story of Hope and Determination
Steven Benvenisti, Quinnipiac University School of Law, USA

10:20-11:00 Title: Neuroactive Steroids as Neuroprotective Agents
Eva Kudova, Czech Academy of Sciences, Czech Republic
Networking and Refreshment Break 11:00-11:20 @ Perfection

11:20-12:00
Title: Music and Memory in Memory Care Units Resulted in Reduction of Unnecessary Usage of
Antipsychotics, Falls and Physical Altercations
Deepa Vinoo, New York City Health and Hospitals, USA

12:00-12:40 Title: Insomnia and risk of dementia in the elderly
Katie Moraes de Almondes, Federal University of Rio Grande do Norte Natal, Brazil

Sessions: Neurochemistry
Session Chair: Hong Ni, National Natural Science Foundation of China, China
Session Introduction

12:40-13:00
Title: Antenatal glucocorticoid administration significantly reduced the immunohistochemical
expression of synaptophysin and locomotor behaviour in adolescent rats
Rodrigo Pascual, Avenida Universidad, Chile

Lunch Break 13:00-13:40 @ Restaurant The Gallery

13:40-14:00
Title: Loss-of-function mutation in RUSC2 causes intellectual disability and secondary
microcephaly
Ali H Alwadei, National Neuroscience Institute, Saudi Arabia

14:00-14:20
Title: Electric axon guidance in embryonic retina: Involvement of integrins
Masayuki Yamashita, International University of Health and Welfare, Japan

14:20-14:40
Title: The Application of Human Mesenchymal Stem Cell for Alzheimer’s Disease
Jong Wook Chang, Samsung Medical Center, South Korea

Sessions: Dementia and Vascular Dementia
Session Chair: Steven Benvenisti, Quinnipiac University School of Law, USA
Session Co-chair: Jacqueline A Hinds, Society of Emotional Intelligence, UK
Session Introduction

14:40-15:00
Title: Management of challenging behaviors in dementia – A Geriatrician’s perspective
Si Ching LIM, Duke-NUS Medical School, Singapore

15:00-15:20
Title: Dementia-App - The caregivers circle
Pieter Hasenaar, ZevHas Lab B.V., The Netherlands

15:20-15:40
Title: Working with migrant communities: Achieving culturally competency in dementia care
Karan Jutlla, De Montfort University, UK

15:40-16:00
Title: Cerebral microbleeds : Innocent or guilty ?
Panteleimon Giannakopoulos, Geneva University School of Medicine, Switzerland
Networking and Refreshment Break 16:00-16:20 @ Perfection

Session Discussion
Sessions: Molecular Neurosciences and Neuro transmitters
Session Chair: Mootaz Salamn, Sheffield Hallam University, UK

Session Introduction
16:20-16:40
Title: S.M.A.R.T. STEROIDS Steroidal Molecules As Rapid-acting Therapeutics
Eva Kudova, Czech Academy of Sciences, Czech Republic

16:40-17:00
Title: Predisposing factor for adjacent-segment failure following lumbar fixation for
degenerative instability
Mohamed Shaban, Cairo University, Egypt

17:00-17:20
Title: Craniopagus parasiticus:Parasitic Head protuberant from temporal area of cranium: A case
report
Getachew Alemayehu, Bahirdar University, Ethiopia

17:20-17:40
Title: Comfort Care In Dementia
Deepa Vinoo, New York City Health and Hospitals, USA

17:40-18:00
Title: Biodistribution and permeability of the blood-brain barrier by biodegradable ZnO
nanoparticles in the living organism
Paula Kiełbik, Warsaw University of Life Sciences, Poland

Session Discussion
----------------------------
Day 2 February 28, 2017
Meeting Hall: 4 & 5
---------------------------

Keynote Forum
09:00-09:40
Title: Interaction of microRNA on HDAC5 expression in Neural Remodeling and Amphetamineinduced
Sensitization
Philip Liu, Harvard Medical School, USA

09:40-10:20
Title: The Dementia Alliance for Culture and Ethnicity: A UK Call to Action on responding to the impact
of dementia in Black, Asian and minority ethnic communities
David Truswell, Culture Dementia UK, United Kingdom

10:20-11:00
Title: Leading Transformation in Healthcare and the role of Emotional Intelligence
Jacqueline A Hinds, Society of Emotional Intelligence, UK
Networking and Refreshment Break 11:00-11:20 @ Perfection

11:20-12:00
Title: Zinc/cPLA2 associated-mitophagy and CaMK II signaling contributed to the neuroprotective
effects of chronic leptin treatment following neonatal seizures
Hong Ni, National Natural Science Foundation of China, China
Special Session

12:00-12:40
Title: Validation of the aquaporin role as a novel drug targets in therapeutic mannitol action and
resistance in cerebral oedema and stroke
Mootaz Salamn, Sheffield Hallam University, UK

Lunch Break 12:40-13:20 @ Restaurant The Gallery

Sessions: Ageing and Dementia, Causes and Prevention
Session Chair: Hanan Sheikh Ibrahim, Cleveland Clinic Abu Dhabi, UAE
Session Co-chair: Katie Moraes de Almondes, Federal University of Rio Grande do Norte Natal, Brazil
Session Introduction

13:20-13:40
Title: Cross-linking non-amyloid CSVD and CAA
Solveig Niklass, Otto-von-Guericke-University, Germany

13:40-14:00
Title: Autoregulation of Cerebral Blood Flow and Elder Diabetes-related Alzheimer’s Disease
Fan Fan, University of Mississippi Medical Center, USA

Sessions: Neuropharmacology| Neurogenesis
Session Chair: Eva Kudova, Czech Academy of Sciences, Czech Republic
Session Introduction

14:00-14:20
Title: Obstructive Sleep Apnea in Dementia
Ramel Carlos, The Neurology Clinic, USA

14:20-14:40
Title: Vesicular trafficking of cholinergic machinery in acetylcholine signaling requires scaffold protein
BNIP-H working in concert with kinesin motor and Rab GTPases
Boon Chuan Low, National University of Singapore, Singapore


14:40-15:00
Title: Minocycline Attenuates Depressive - Like Behaviour Induced by Rat Model of Testicular Torsion:
Involvement of Nitric Oxide Pathway
Seyyedeh Elaheh Mousavi, Tehran University of Medical Sciences, Iran

15:00-15:20
Title: The effect of nitrazepam on depression and curiosity in behavioral tests in mice: The role of
potassium channels
Azam Bakhtiarian, Tehran University of Medical Sciences, Iran

15:40-16:00
Title: Evaluation of chronic losartan treatment effect on cardiac chronotropic dysfunction in biliary
cirrhotic rats
Farahnaz Jazaerijooneghani, Tehran University of Medical Sciences, Iran

Networking and Refreshment Break 16:00-16:20 @ Perfection

Poster Presentations
16:00-17:00
Title: Environmental enrichment recovers the immunohistochemical underexpression of neurotrophin-3
(NT3) together with anxiety-like behavior in rats prenatally treated with synthetic glucocorticoids
Martina Valencia, Avenida Universidad, Chile
Title: Induction of depressive-like and anxiety-like effects by subchronic exposure to lead in Wistar Rats
Jihane Chaibat, Laboratory of NeuroEndocrinology and Biotechnology, Morocco
Title: Effect of chronic administration of Cadmium on affective disorders
Lamati Mouloud, Laboratory of NeuroEndocrinology and Biotechnology, Morocco
Title: Alzheimer’s disease and its Prevention: Epidemiology
Seth Omari Mensah, Kharkov National Medical University, Ukraine
Title: Project to improve management following a head injury for acute Medical admissions and
reduce CT Head requests as per NICE Guidance
Nisha Rajcoomar, Mid Essex Hospitals NHS Trust, UK
Title: Posterior Cortical Atrophy: A case of late-onset disease presenting with memory loss
Stefanos Ioannidis, Royal Free Hospital, UK
Title: Cross-linking non-amyloid CSVD and CAA
Solveig Niklass, Otto-von-Guericke-University, Germany

--------------------------------
Day 3 March 01, 2017
Meeting Hall: 4 & 5
-------------------------------
09:30-10:10
Title: Snoezelen in the 24 care for people with dementia
Ad Verheul, De Hartenberg, The Netherlands
Special Session

10:10-10:40
Title: The mechanism of Aquaporin expression and translocation in cerebral pathologies
Mootaz Salman, Sheffield Hallam University/ Biomedical research Center, UK
Networking and Refreshment Break 10:40-11:00 @ Perfection

Sessions: Dementia Care Management
Session Chair: David Truswell, Culture Dementia UK, United Kingdom
Session Co-chair: Hanan Sheikh Ibrahim, Cleveland Clinic Abu Dhabi, UAE
Session Introduction

11:00-11:20 Nkeng Forze Alexis, District Hospital, Cameroon
11:20-11:40 Fontem Fonki Alain, District Hospital, Cameroon
11:40-12:00 Ekuka Owasu Okpoh, District Hospital, Cameroon

Sessions: Animal Models and Translational Medicine
Session Chair: David Truswell, Culture Dementia UK, United Kingdom
Session Co-chair: Steven Benvenisti, Quinnipiac University School of Law, USA
Session Introduction

12:00-12:20 Title: Posterior Cortical Atrophy: A case of late-onset disease presenting with memory loss
Stefanos Ioannidis, Royal Free Hospital, UK

12:20-12:40
Title: A case of unrecognized Dementia in young frail patient with subcortical white matter disease
masquerades as depression, non compliance and repeated hypoglycemia
Hanan Sheikh Ibrahim, Cleveland Clinic Abu Dhabi, UAE

Lunch Break 13:00-14:30 @ Restaurant The Gallery

Award & Closing Ceremony

Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS
Service fees included in this listing.
-----------------------------------------------------------------
This event is brought to you by:
Conference Series - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

MYL180503CEV MYL180627UPA VIO180925UPD

Share with friends

Date and Time

Location

Venue will be informed to the Registered Participants

Stockholm

Sweden

View Map

Refund Policy

No Refunds

Save This Event

Event Saved